Price
No data yet.
Social Signal Score
Revenue
$0.00Company Profile
- CEO
- Dean E. Burns
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Employees
- 3
- Beta
- 0.34
- Country
- CA
- Piotroski score
- 1 / 9 (Weak)
- Altman Z-score
- -65.64
Financials
Net Income
$-484.7KEBITDA
$-858.4KFree Cash Flow
$-302.4K-179970338.1%EPS (diluted)
$-0.00Shares Outstanding (diluted)
132.30M+495.9%Operating Expenses
$858.4KCash & Debt
$88.7KReturn of Capital
$0.00Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $0.00 | $-5.37M | $-0.04 |
| 2024 | $0.00 | $-3.02M | $-0.03 |
| 2023 | $0.00 | $-3.64M | $-0.03 |
| 2022 | $0.00 | $-2.22M | $-0.02 |
| 2021 | $0.00 | $-598.2K | $-0.01 |
| 2020 | $0.00 | $-172.5K | $-0.06 |
| 2019 | $0.00 | $-35.7K | $-0.01 |
| 2018 | $0.00 | $-76.0K | $-0.07 |
Valuation
OTCFFhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
100+25.00%Social Signal Score
Mentions (2)
- Newsthenewswire.com·5h ago·Neutral
Ocumetics Announces Initiation of Patient Recruitment for Upcoming Group Two Human Clinical Surgeries Key Highlights Group Two clinical study underway - Patient recruitment has begun in Mexico City, with surgeries targeted for Fall 2026 .
View source ↗ - Newsthenewswire.com·8d ago·Negative
Ocumetics Completes Manufacturing of Next Generation Solid State Accommodating Intraocular Lenses for Upcoming Group Two First in Human Clinical Surgeries Key Highlights Next-generation Ocumetics Lenses successfully manufactured and ready for the Company's upcoming Group Two first-in-human clinical surgeries in Mexico City.
View source ↗
Earnings
Tue, Nov 24(in 3 months)
Estimates and results for OTCFF via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.